International journal of dermatology, vol.54, no.5, pp.594-9, 2015 (Journal Indexed in SCI Expanded)
BackgroundTumor necrosis factor-alpha (TNF-) antagonist treatment is associated with 1.6 to 27 times higher risk of tuberculosis (TB).